Cargando…

Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays

This study compares the diagnostic performance of a second generation anti-cyclic citrullinated peptide antibody (CCP2) with a third generation anti-CCP antibodies assay (CCP3), as well as the combination of both tests. Serum samples of 127 patients were analyzed. IgG anti-CCP 2 and IgM rheumatoid f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vos, Ine, Van Mol, Christof, Trouw, Leendert A., Mahler, Michael, Bakker, Jaap A., Van Offel, Jan, De Clerck, Luc, Huizinga, Tom W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486477/ https://www.ncbi.nlm.nih.gov/pubmed/28578492 http://dx.doi.org/10.1007/s10067-017-3684-8

Ejemplares similares

Anti-CCP antibodies and bone
por: Orsolini, Giovanni, et al.
Publicado: (2018)

Identification of potential autoantigens in anti-CCP-positive and anti-CCP-negative rheumatoid arthritis using citrulline-specific protein arrays
por: Poulsen, Thomas B. G., et al.
Publicado: (2021)

The association of anti-CCP antibodies with disease activity in rheumatoid arthritis
por: Serdaroğlu, Münevver, et al.
Publicado: (2008)

P01-019 – Anti-CCP antibodies are not associated with FMF
por: Onur, H, et al.
Publicado: (2013)

The clinical significance of anti-CCP antibodies in Korean JRA patients
por: Kim, Kwang Nam, et al.
Publicado: (2014)

Anti-CCP Antibodies Are Not Associated with Familial Mediterranean Fever in Childhood
por: Onur, Hatice, et al.
Publicado: (2013)

The Influence of Polygenic Risk Scores on Heritability of Anti-CCP Level in RA
por: Cui, Jing, et al.
Publicado: (2014)

Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
por: Nicaise Roland, Pascale, et al.
Publicado: (2008)

Anti-Cyclic Citrullinated Peptide (Anti-CCP) and Anti-Mutated Citrullinated Vimentin (Anti-MCV) Relation with Extra-Articular Manifestations in Rheumatoid Arthritis
por: Gonzalez-Lopez, Laura, et al.
Publicado: (2014)

Relation Between Anti-CCP Antibodies and Sharp Score in Rheumatoid Arthritis
por: Mekic, Mevludin, et al.
Publicado: (2020)

Anti-CCP: History and its Usefulness
por: Herold, M., et al.
Publicado: (2005)

Dendritic cell immunoreceptor (DCIR) is associated with anti-cyclic citrullinated peptides (anti-CCP) antibody - negative rheumatoid arthritis in Chinese Han population
por: Guo, Jianping, et al.
Publicado: (2012)

Relationship between Anti-CCP Antibodies and Oxidant and Anti-Oxidant Activity in Patients with Rheumatoid Arthritis
por: Ediz, Levent, et al.
Publicado: (2011)

Anti-CCP2 Antibodies: An Overview and Perspective of the Diagnostic Abilities of this Serological Marker for Early Rheumatoid Arthritis
por: van Venrooij, Walther J., et al.
Publicado: (2007)

Systematic review and meta-analysis of the risk of rheumatoid arthritis-associated interstitial lung disease related to anti-cyclic citrullinated peptide (CCP) antibody
por: Kamiya, Hiroyuki, et al.
Publicado: (2021)

Effects of Human Leukocyte Antigen DRB1 Genetic Polymorphism on Anti-Cyclic Citrullinated Peptide (ANTI-CCP) and Rheumatoid Factor (RF) Expression in Rheumatoid Arthritis (RA) Patients
por: Chen, Yu-Chia, et al.
Publicado: (2023)

Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?
por: De Rooy, Diederik PC, et al.
Publicado: (2011)

Anti-CCP Antibody Levels Are Not Associated with MS: Results from a Case-Control Study
por: Alpayci, Mahmut, et al.
Publicado: (2015)

Correlation between high-frequency ultrasonography of patients with early rheumatoid arthritis and anti-CCP antibody
por: Yang, Jie, et al.
Publicado: (2019)

Ability of second-generation anti-cyclic citrullinated peptide (CCP) to predict rheumatoid arthritis in patients with early arthritis
por: Saraux, A, et al.
Publicado: (2003)

Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis
por: Habets, Kim L.L., et al.
Publicado: (2015)

Adjusting for sex and anti-CCP levels in linkage analysis of rheumatoid arthritis
por: Lebrec, Jérémie JP, et al.
Publicado: (2007)

Serum levels of anti-CCP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab
por: Fabris, Martina, et al.
Publicado: (2010)

Low levels of anti-cyclic citrullinated peptide (CCP) 3.1 associated with diseases other than rheumatoid arthritis
por: Son, James J., et al.
Publicado: (2021)

In Contrast to Anti-CCP, MMP-Degraded and Citrullinated Vimentin (VICM) Is Both a Diagnostic and a Treatment Response Biomarker
por: Drobinski, Patryk J., et al.
Publicado: (2022)

The association of anti-CCP1 antibodies with disease activity score 28 (DAS-28) in rheumatoid arthritis
por: Karimifar, Mansoor, et al.
Publicado: (2012)

Differential regulation and correlation between galectin-9 and anti-CCP antibody (ACPA) in rheumatoid arthritis patients
por: Fujita, Yuya, et al.
Publicado: (2020)

The Clinical Application of Anti-CCP in Rheumatoid Arthritis and Other Rheumatic Diseases
por: Chou, CT, et al.
Publicado: (2007)

The fine specificity of IgM anti-citrullinated protein antibodies (ACPA) is different from that of IgG ACPA
por: Suwannalai, Parawee, et al.
Publicado: (2011)

Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCP) affects severity of rheumatoid arthritis
por: van Gaalen, FA, et al.
Publicado: (2004)

CCP5 and CCP6 retain CP110 and negatively regulate ciliogenesis
por: Wang, Yujuan, et al.
Publicado: (2023)

Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage
por: Brink, Mikael, et al.
Publicado: (2015)

The reporting quality of studies investigating the diagnostic accuracy of anti-CCP antibody in rheumatoid arthritis and its impact on diagnostic estimates
por: Zintzaras, Elias, et al.
Publicado: (2012)

A Closer Look at the Role of Anti-CCP Antibodies in the Pathogenesis of Rheumatoid Arthritis-Associated Interstitial Lung Disease and Bronchiectasis
por: Khan, Tanjila, et al.
Publicado: (2021)

Rheumatoid Arthritis Co-relation with Anti-CCP Antibodies with special reference to its Prevalence in Asymptomatic First-Degree Relatives
por: GR, Pramod, et al.
Publicado: (2022)

The influence of the -94 Ins/Del ATTG polymorphism of NFkB on the anti-CCP antibody levels in patients with rheumatoid arthritis
por: Ayón-Pérez, Miriam Fabiola, et al.
Publicado: (2021)

Tocilizumab Efficacy in a Patient with Positive Anti-CCP Chronic Lyme Arthritis
por: Hirsch, Julianna, et al.
Publicado: (2016)

Anti-CCP-positive patients with RA have a higher 10-year probability of fracture evaluated by FRAX®: a registry study of RA with osteoporosis/fracture
por: Cheng, Tien-Tsai, et al.
Publicado: (2018)

Correction to: A Closer Look at the Role of Anti-CCP Antibodies in the Pathogenesis of Rheumatoid Arthritis Associated Interstitial Lung Disease and Bronchiectasis
por: Khan, Tanjila, et al.
Publicado: (2021)

Ligand fitting with CCP4
por: Nicholls, Robert A.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8hf3p5et69jssfsup01mejr73k